Dolby Laboratories, Inc.
DLB
$61.06
-$3.44-5.33%
NYSE
| 12/26/2025 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Net Income | 240.52M | 255.02M | 264.26M | 256.63M | 262.67M |
| Total Depreciation and Amortization | 100.21M | 98.60M | 98.41M | 95.21M | 91.56M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 140.12M | 138.93M | 111.46M | 102.64M | 104.48M |
| Change in Net Operating Assets | -60.64M | -20.35M | -8.59M | -35.38M | -33.08M |
| Cash from Operations | 420.22M | 472.20M | 465.54M | 419.11M | 425.62M |
| Capital Expenditure | -34.20M | -36.35M | -27.48M | -28.67M | -30.69M |
| Sale of Property, Plant, and Equipment | 16.88M | 16.88M | 16.88M | 16.88M | -- |
| Cash Acquisitions | 0.00 | -1.36M | -489.24M | -489.24M | -489.24M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.12M | 10.24M | 249.86M | 249.73M | 224.86M |
| Cash from Investing | -1.20M | -10.59M | -249.98M | -251.30M | -295.07M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 35.79M | 43.70M | 39.40M | 36.98M | 44.06M |
| Repurchase of Common Stock | -216.25M | -162.49M | -147.05M | -142.23M | -131.95M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -129.39M | -126.60M | -123.62M | -120.69M | -117.58M |
| Other Financing Activities | -1.65M | -1.85M | -12.03M | -15.02M | -14.78M |
| Cash from Financing | -311.50M | -247.24M | -243.30M | -240.96M | -220.25M |
| Foreign Exchange rate Adjustments | 8.39M | 1.24M | 5.69M | -869.00K | -7.31M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.91M | 215.61M | -22.06M | -74.01M | -97.00M |